Bacteriophage Therapy for Orthopedic Implant-Associated Infections

Inclusion Criteria: * Known allergy or hypersensitivity to bacteriophages or any components of the bacteriophage preparation; * Pregnant or breastfeeding women; * Participation in another interventional clinical trial within the study period; * Lack of feasible routes of administration other than intravenous injection; * Patients deemed unsuitable for participation in this study by the investigator; * Inability or unwillingness of the subject to comply with study procedures. Exclusion Criteria: * Withdrawal of informed consent by the participant at any time during the study; * Occurrence of serious adverse events related to bacteriophage therapy that, in the investigator's judgment, necessitate discontinuation of treatment.